Агафьина Алина Сергеевна

02-GamTBvac-2020^{ClinicalTrials.gov}

Статус:	Recruiting
Фаза:	Phase 3
Начало:	20 января 2022 г.
Окончание:	1 ноября 2025 г.
Описание:	This is a multicenter, double-blind, randomized (in 1:1 ratio) placebo-controlled study to assess the safety and protective efficacy of the subunit recombinant tuberculosis vaccine GamTBvac against the development of respiratory tuberculosis not associated with HIV infection in volunteers aged 18-45 years.
	смотреть на ClinicalTrials.gov

Статус:	Unknown status
Фаза:	Phase 3
Начало:	19 февраля 2021 г.
Окончание:	31 января 2022 г.
Описание:	The study Global sponsor is planning several parallel studies of Sputnik-Light vector vaccine across the globe in United Arab Emirates, Russia and possibly in other countries in case of confirmation associated with the same medical product under similar protocols. The key objective of this study is to be conducted in several parallel studies of the same vaccine above the other countries. Using similar protocols on a portfolio basis of studies let us collect data for Efficacy, Immunogenicity, Safety and Tolerability confirmation of the Sputnik-Light vaccine.
	смотреть на ClinicalTrials.gov